radiopharmaceutical

Open Access
Reduced Renal Uptake of Various Radiopharmaceuticals with Sodium Paraaminohippurate Coadministration in a Rat Model
Marian Meckel, Stefanie Ehrenberg, Theresa Schmidt, Philipp Ritt, Margret I. Moré, Ralf Bergmann, Domokos Mathe and Konstantin Zhernosekov

Journal of Nuclear Medicine May 1, 2025, 66 (5) 806-812; DOI: https://doi.org/10.2967/jnumed.124.268411
Open Access
Preclinical Evaluation of ¹⁷⁷Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy
Caroline Foxton, Bradley Waldron, Rikke Veggerby Grønlund, Jaime (Jim) Simón, Bart Cornelissen, Edward O’Neill and Daniel Stevens

Journal of Nuclear Medicine April 1, 2025, 66 (4) 599-604; DOI: https://doi.org/10.2967/jnumed.124.268508
You have access
Preclinical Evaluation of ⁶⁸Ga/¹⁷⁷Lu-Labeled FAP-Targeted Peptide for Tumor Radiopharmaceutical Imaging and Therapy
Rang Wang, Mingxing Huang, Weichen Wang, Mufeng Li, Yingwei Wang and Rong Tian

Journal of Nuclear Medicine February 1, 2025, 66 (2) 250-256; DOI: https://doi.org/10.2967/jnumed.124.268689
You have access
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy
Clara Diaz Garcia-Prada, Léna Carmes, Salima Atis, Ali Parach, Alejandro Bertolet, Marta Jarlier, Sophie Poty, Daniel Suarez Garcia, Wook-Geun Shin, Stanislas Du Manoir, Jan Schuemann, Olivier Tillement, François Lux, Julie Constanzo and Jean-Pierre Pouget

Journal of Nuclear Medicine December 1, 2023, 64 (12) 1956-1964; DOI: https://doi.org/10.2967/jnumed.123.265418
You have access
Dosimetry in Radiopharmaceutical Therapy
Joe O’Donoghue, Pat Zanzonico, John Humm and Adam Kesner

Journal of Nuclear Medicine October 1, 2022, 63 (10) 1467-1474; DOI: https://doi.org/10.2967/jnumed.121.262305
You have access
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted ¹⁸F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, François Bénard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho and Steven P. Rowe

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1430-1437; DOI: https://doi.org/10.2967/jnumed.120.259069
You have access
Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy
Michael Gabriel, Bernhard Nilica, Bernhard Kaiser and Irene J. Virgolini

Journal of Nuclear Medicine April 1, 2019, 60 (4) 524-529; DOI: https://doi.org/10.2967/jnumed.118.215376
You have access
Evaluation of the Efficacy of Targeted Imaging Agents
Michael M. Graham and Wolfgang A. Weber

Journal of Nuclear Medicine April 1, 2016, 57 (4) 653-659; DOI: https://doi.org/10.2967/jnumed.115.169235
You have access
New Approaches for Modeling Radiopharmaceutical Pharmacokinetics Using Continuous Distributions of Rates
Igor Shuryak and Ekaterina Dadachova

Journal of Nuclear Medicine October 1, 2015, 56 (10) 1622-1628; DOI: https://doi.org/10.2967/jnumed.115.160515
You have access
Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors
Clément Morgat, Anil Kumar Mishra, Raunak Varshney, Michèle Allard, Philippe Fernandez and Elif Hindié

Journal of Nuclear Medicine October 1, 2014, 55 (10) 1650-1657; DOI: https://doi.org/10.2967/jnumed.114.142000

Main menu

User menu

Search

radiopharmaceutical

Pages